McGovern Lecture in Health Communication: Julie Gerberding

The UT Center for Health Communications presents Julie Gerberding, Executive Vice President and Chief Patient Officer, Strategic Communications, Global Public Policy, and Population Health at Merck & Co., Inc.

Thu, September 20, 2018 | Belo Center for New Media (BMC) 5.208

3:30 PM - 5:00 PM

The UT Center for Health Communications presents Julie Gerberding, Executive Vice President and Chief Patient Officer, Strategic Communications, Global Public Policy, and Population Health at Merck & Co., Inc. where she also has responsibility for the Merck for Mothers program and the Merck Foundation.

As a world-renowned infectious disease and public health expert, Dr. Gerberding is a leader well-versed in and passionate about acting with purpose and urgency to meet patient needs. She joined Merck in January 2010 as president of Merck Vaccines and, during her leadership of that business, helped make the company’s vaccines increasingly more available and affordable to people in emerging markets and some of the most resource-limited countries in the world. Dr. Gerberding also helped lead the successful launch in India of the MSD Wellcome Trust Hilleman Laboratories, a not-for-profit joint venture for vaccine development. In 1998, she left her tenured academic faculty appointment at the University of California, San Francisco, to lead the U.S. Centers for Disease Control and Prevention (CDC) Division of Healthcare Quality Promotion and then served as the CDC Director from 2002 to 2009.

Dr. Gerberding was recently honored as the Healthcare Businesswomen's Association (HBA) 2018 Woman of the Year for her contributions to health as a physician, infectious disease expert, first female director of the CDC, and for her leadership roles at Merck. Condoleezza Rice, former U.S. Secretary of State, reflected in a video message on some of Dr. Gerberding’s achievements: “I’ve worked side by side with Julie during some of the toughest times,” she said. “We dealt with global pandemics like the avian flu. We dealt with post-9/11 threats of biological warfare. We dealt with the anthrax attack and alarm over smallpox.”

Bookmark and Share


  •   Map
  • Population Research Center

    University of Texas at Austin
    305 E. 23rd Street / RLP 2.602
    Mail Stop G1800
    Austin, Texas 78712-1699
    512-471-5514